Cargando…

977. Bacterial STI Diagnoses as Missed Opportunities for HIV Pre-Exposure Prophylaxis

BACKGROUND: New HIV diagnoses in the United States have remained stagnant while the incidence has increased among certain groups; additional efforts towards HIV prevention are needed. Most adults who could benefit from HIV Pre-Exposure Prophylaxis (PrEP) in the United States are not receiving it. Ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reddy, Archana K, Salazar, Jorge, Waldman, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777554/ http://dx.doi.org/10.1093/ofid/ofaa439.1163

Ejemplares similares

P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA
por: Alp Kirkizlar, Tugcan, et al.
Publicado: (2023)

Missed Opportunities to Initiate Pre-exposure Prophylaxis in South Carolina—2013–2016
por: Okoye, Stella, et al.
Publicado: (2017)

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort
por: Lions, C., et al.
Publicado: (2019)

Missed opportunities for sexually transmitted infections testing for HIV pre‐exposure prophylaxis users: a systematic review
por: Ong, Jason J, et al.
Publicado: (2021)

Are Opportunities Being Missed? Burden of HIV, STI and TB, and Unawareness of HIV among African Migrants
por: Dias, Sónia, et al.
Publicado: (2019)

P977: BISPECIFIC CS1-BCMA CAR-T CELLS ARE CLINICALLY ACTIVE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
por: Li, C., et al.
Publicado: (2022)

Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV
por: Ballreich, Jeromie, et al.
Publicado: (2022)

HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019
por: Koppe, Uwe, et al.
Publicado: (2022)

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
por: Kim, Susan C, et al.
Publicado: (2010)

HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis
por: Chemtob, Daniel, et al.
Publicado: (2021)

Study Evaluating Self-Collected Specimen Return for HIV, Bacterial STI, and Potential Pre-Exposure Prophylaxis Adherence Testing Among Sexual Minority Men in the United States
por: Sharma, Akshay, et al.
Publicado: (2022)

HIV diagnoses in Australia fall as clinicians embrace pre-exposure prophylaxis
por: Medland, Nicholas A, et al.
Publicado: (2020)

The impact of HIV pre-exposure prophylaxis on sexually transmitted infections incidence in Bulgaria
por: Pakov, I, et al.
Publicado: (2023)

Phenotypic factors associated with outcome in 977 intensive care patients with faecal peritonitis: analysis of trends in the GenOSept cohort
por: Tridente, A, et al.
Publicado: (2015)

HIV Pre-Exposure Prophylaxis (PrEP) Counseling in Germany: Knowledge, Attitudes and Practice in Non-governmental and in Public HIV and STI Testing and Counseling Centers
por: Kutscha, Frank, et al.
Publicado: (2020)

1296. Potential use of Sexually Transmitted Infection (STI) Testing for Expanding HIV Pre-Exposure Prophylaxis (PrEP) at an Urban Hospital Center
por: Pitts, Robert, et al.
Publicado: (2018)

Pre-exposure prophylaxis of HIV
por: Naswa, Smriti, et al.
Publicado: (2011)

Pre-exposure prophylaxis in HIV
por: Khambhati, Ravi, et al.
Publicado: (2009)

HIV: Pre-exposure Prophylaxis
por: Singh, Ajai Kumar, et al.
Publicado: (2012)

Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India
por: Mayer, Kenneth H., et al.
Publicado: (2016)

Pre-exposure prophylaxis as an opportunity for engagement in HIV prevention among South African adolescents
por: LoVette, Ashleigh, et al.
Publicado: (2022)

954. Missed opportunities for HIV Screening in the Emergency Department
por: Hirsch, Amanda, et al.
Publicado: (2020)

P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis
por: Sarazin, V, et al.
Publicado: (2009)

Syphilis – not just a STI
por: Robinson, Victoria
Publicado: (2010)

Missed opportunities for HIV testing among those who accessed sexually transmitted infection (STI) services, tested for STIs and diagnosed with STIs: a systematic review and meta‐analysis
por: Saleem, Kanwal, et al.
Publicado: (2023)

Missed opportunities to offer HIV tests to high-risk groups during general practitioners’ STI-related consultations: an observational study
por: Joore, I K, et al.
Publicado: (2016)

103. Persistence on F/TDF for HIV Pre-exposure Prophylaxis: Insights from Real-world Evidence
por: Tao, Li, et al.
Publicado: (2020)

COVID-19 Pandemic, Pre-exposure Prophylaxis (PrEP) Care, and HIV/STI Testing Among Patients Receiving Care in Three HIV Epidemic Priority States
por: Hill, Brandon J., et al.
Publicado: (2021)

Missed opportunities to prevent HIV infections among pre‐exposure prophylaxis users: a population‐based mixed methods study, San Francisco, United States
por: Spinelli, Matthew A, et al.
Publicado: (2020)

Evaluation of multiple data sources for predicting increased need for HIV prevention among cisgender women: understanding missed opportunities for Pre-exposure Prophylaxis (PrEP)
por: Johnson, Amy K., et al.
Publicado: (2023)

Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?
por: Molina, Jean-Michel, et al.
Publicado: (2013)

HIV pre-exposure prophylaxis for women
por: Sheth, Anandi N, et al.
Publicado: (2016)

Modeling HIV Pre-Exposure Prophylaxis
por: Straubinger, Thomas, et al.
Publicado: (2020)

Prescribing pre-exposure prophylaxis for HIV
por: Bloch, Mark
Publicado: (2020)

P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
por: Ntanasis-Stathopoulos, I., et al.
Publicado: (2023)

Missed opportunities for HIV testing in patients newly diagnosed with HIV in Morocco
por: Marih, Latifa, et al.
Publicado: (2021)

Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California
por: Hunter, Lauren A, et al.
Publicado: (2023)

102. Improving Implementation of HIV Pre-exposure Prophylaxis: Lessons Learned from Young Women in Rural South Africa
por: Hannaford, Alisse, et al.
Publicado: (2020)

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
por: Oglesby, Alan, et al.
Publicado: (2021)

851. Rate of Sexually Transmitted Infections and Engagement in HIV Pre-Exposure Prophylaxis at the Veterans Affair Maryland Health System
por: Harfouch, Omar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tkavhl4nrdg7u7rm9oprnvr1eo